- Author:
Renan BRAGA
1
,
2
;
Humberto ANDRADE
1
,
2
;
Ryldene CRUZ
1
,
2
;
Mayara MAIA
1
,
2
;
Carolina LIMA
1
,
2
;
Allana DUARTE
1
,
2
;
Anderson SANTOS
3
,
4
;
André MIRANDA
3
,
4
;
Marcus SCOTTI
3
,
4
;
Reinaldo ALMEIDA
3
,
4
;
Damião SOUSA
3
,
4
;
Reinaldo ALMEIDA
2
,
5
;
Damião SOUSA
2
,
5
Author Information
- Publication Type:Journal Article
- Keywords: Analgesic; Biological products; Essential oil; Monoterpene; Opioid; Pain; Perillyl acetate
- From:Asian Pacific Journal of Tropical Biomedicine 2022;12(4):156-163
- CountryChina
- Language:English
- Abstract: Objective: To evaluate the antinociceptive activity of perillyl acetate in mice and in silico simulations. Methods: The vehicle, perillyl acetate (100, 150 and/or 200 mg/kg, i.p.), diazepam (2 mg/kg, i.p.) or morphine (6 mg/kg, i.p.) was administered to mice, respectively. Rotarod test, acetic acid-induced abdominal writhing, formalin-induced nociception, hot plate test, and tail-flick test were performed. Opioid receptors-involvement in perillyl acetate antinociceptive effect was also investigated. Results: Perillyl acetate did not affect the motor coordination of mice. However, it reduced the number of acetic acid-induced abdominal twitches and licking times in the formalin test. There was an increase of latency time in the tail-flick test of 30 and 60 minutes. Pretreatment with naloxone reversed the antinociceptive effect of perillyl acetate (200 mg/kg). In silico analysis demonstrated that perillyl acetate could bind to μ-opioid receptors. Conclusions: Perillyl acetate has antinociceptive effect at the spinal level in animal nociception models, without affecting the locomotor integrity and possibly through μ-opioid receptors. In silico studies have suggested that perillyl acetate can act as a μ-opioid receptor agonist.